HTR6 and Alzheimer disease: 5-HT6R blockade has been proposed as a treatment of Alzheimer’s disease (AD) symptoms, however, the strategy ultimately failed, with no drugs on the market so far despite intensive clinical trial campaigns led by several companies [6,7,8,9].